Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis
Open Access
- 8 December 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 14 (3) , 357-372
- https://doi.org/10.1093/hmg/ddi032
Abstract
Huntington's disease (HD) is caused by expansion of a polyglutamine tract near the N-terminal of huntingtin. Mutant huntingtin forms aggregates in striatum and cortex, where extensive cell death occurs. We used a Drosophila polyglutamine peptide model to assess the role of specific cell death regulators in polyglutamine-induced cell death. Here, we report that polyglutamine-induced cell death was dramatically suppressed in flies lacking Dark, the fly homolog of human Apaf-1, a key regulator of apoptosis. Dark appeared to play a role in the accumulation of polyglutamine-containing aggregates. Suppression of cell death, caspase activation and aggregate formation were also observed when mutant huntingtin exon 1 was expressed in homozygous dark mutant animals. Expanded polyglutamine induced a marked increase in expression of Dark, and Dark was observed to colocalize with ubiquitinated protein aggregates. Apaf-1 also was found to colocalize with huntingtin-containing aggregates in a murine model and HD brain, suggesting a common role for Dark/Apaf-1 in polyglutamine pathogenesis in invertebrates, mice and man. These findings suggest that limiting Apaf-1 activity may alleviate both pathological protein aggregation and neuronal cell death in HD.Keywords
This publication has 86 references indexed in Scilit:
- Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's diseaseCell Death & Differentiation, 2004
- Dominant ataxias and Friedreich ataxiaCurrent Opinion in Neurology, 2003
- Huntingtin aggregation and toxicity in Huntington's diseaseThe Lancet, 2003
- Huntingtin in health and diseaseJournal of Clinical Investigation, 2003
- Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysisProceedings of the National Academy of Sciences, 2001
- Glutamine Repeats and NeurodegenerationAnnual Review of Neuroscience, 2000
- Caspase-8 Is Required for Cell Death Induced by Expanded Polyglutamine RepeatsNeuron, 1999
- Huntingtin localization in brains of normal and Huntington's disease patientsAnnals of Neurology, 1997
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Neuropathological Classification of Huntingtonʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1985